Lo Andrew sold BBIO
November 18, 2025 · Form 4 insider transaction
Lo Andrew sold 24,007 shares of BridgeBio Pharma, Inc. at $65.23 per share, a transaction worth $1.57M. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Disposed (sell-side)
Shares
24,007
Price
$65.23
Total value
$1.57M
InsiderLo Andrew
Role—
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateNovember 18, 2025
Filing dateNovember 19, 2025
Shares owned after81,576
OwnershipIndirect
10b5-1 planNo
AmendedNo
Footnotes
Represents the weighted average sale price of the shares sold from $64.58 to $65.56 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.